Author

N. J. Shehadeh

Observed names: N J Shehadeh, N Shehadeh, N. Shehadeh, Nasfat J Shehadeh, Nasfat J. Shehadeh, Nasfat Shehadeh

Observed institutions: University of Minnesota, Wayne State University, University of Michigan, The Barbara Ann Karmanos Cancer Institute, Children's Hospital of Michigan

OpenAlex ID: A5072505317

PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)

2024 · Rahul Aggarwal, Glenn Heller, et al. · Journal of Clinical Oncology · 54

Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: a case report and review of the literature

2003 · Nasfat J Shehadeh, John Vernick, et al. · American Journal of Otolaryngology · 51

Phase I study of bortezomib and cetuximab in patients with solid tumours expressing epidermal growth factor receptor

2009 · A Z Dudek, K Lesniewski-Kmak, et al. · British Journal of Cancer · 44

Benefit of postoperative chemoradiotherapy for patients with unknown primary squamous cell carcinoma of the head and neck

2006 · Nasfat J. Shehadeh, John F. Ensley, et al. · Head & Neck · 36

Enhancement of Ad‐p53 Therapy with Docetaxel in Head and Neck Cancer

2004 · George H. Yoo, Marie P. Piechocki, et al. · The Laryngoscope · 27

An In Vivo Evaluation of Docetaxel Delivered Intratumorally in Head and Neck Squamous Cell Carcinoma

2005 · George H. Yoo, Geetha Subramanian, et al. · Archives of Otolaryngology - Head and Neck Surgery · 14

Celecoxib (CEL) and weekly docetaxel (DOC) in elderly or PS2 patients (pts) with advanced non-small cell lung cancer (NSCLC)

2004 · R. A. Chaplen, G. P. Kalemkerian, et al. · Journal of Clinical Oncology · 10

Cyclophosphamide-induced methemoglobinemia

2003 · N Shehadeh, R Dansey, et al. · Bone Marrow Transplantation · 7

Gefitinib and celecoxib in patients with platinum refractory non-small cell lung cancer (NSCLC)

2004 · S. M. Gadgeel, N. J. Shehadeh, et al. · Journal of Clinical Oncology · 3

Phase I study of bortezomib plus cetuximab in patients with tumors expressing epidermal growth factor receptor (EGFR)

2007 · A. Dudek, P. Gada, et al. · Journal of Clinical Oncology · 2

Unknown head and neck primary: Treatment with neck dissection followed by concurrent chemoradiotherapy

2004 · N. J. Shehadeh, M. Becker, et al. · Journal of Clinical Oncology

Works count: 11

Citation count: 248

H-index: 7

I10-index: 7